← Insider buys
HTGM

Htg Molecular Diagnostics, Inc

Glaxosmithkline Plc sold $3.0M of Htg Molecular Diagnostics, Inc

Former 10% Owner

Sold$3,045,180
$10.15Price
300,000Shares
−27%Stake

What HTGM did after the filing

Prices for HTGM after this filing aren't in yet.

Traded Mon, Mar 27. Filed Thu, Mar 30, 4:11 PM ET, after the close. Not investment advice.